CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 33 enrolled
Drug / intervention
Oxygendrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03268590
NCT03268590Phase 4Completed

Hyperoxia: An Unrecognized Mechanism for Inducing "Hypoxia-Like" Symptoms

Case Western Reserve University·interventional·Posted Aug 31, 2017·Updated Nov 13, 2019

In Brief

A Phase 4 clinical trial evaluating Oxygen for Hyperoxia and 2 related conditions. Completed, enrolled 33 participants across 1 site.

Detailed Summary

The investigators will conduct a non-randomized clinical trial to examine the effect of pure oxygen breathing on the brain. The study will compare cerebral blood flow, cortical electrical activity, and cognitive performance in 32 persons during room air (21% oxygen) breathing and pure oxygen (100% oxygen) breathing. Subjects will be used as their own controls. The investigators aim to: 1. Determine whether breathing 100% oxygen changes blood flow through the brain. The investigators will learn whether brain blood flow is increased, decreased or stays the same. 2. Determine if changes that might occur in brain blood flow are also accompanied by changes in the brain's electrical activity (EEG). 3. Learn whether changes in the speed at which the brain processes information (cognitive function) accompany changes in brain blood flow and electrical activity that may be seen.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedAug 31, 2017
Enrollment StartOct 2, 2017
Primary CompletionMay 2, 2018
Study CompletionMay 9, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.8 years ago

Interventions

Oxygendrug

Persons will undergo MRI, EEG, and complete computerized cognitive testing in baseline room air. Persons will then breathe 100% pure oxygen and undergo MRI, EEG, and complete computerized cognitive testing. Persons will serve as their own controls.